>
pdufa.bio

Niraparib

Updated ยทnext FDA decision on the calendar

Niraparib is a Myriad Genetics Inc program. Its next catalyst is a Readout in Nov 2027. Every date links its source.

MYGN catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Myriad Genetics Inc (MYGN). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Nov 2027MYGN

Questions

When is Niraparib's next FDA decision or readout?

The next tracked catalyst for Niraparib is a Readout in Nov 2027.

What happened at Niraparib's most recent FDA decision?

No FDA decision for Niraparib is in our archive yet.

Who makes Niraparib?

Myriad Genetics Inc (MYGN).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.